Laboratory Assay Optimization 2.0

Overview

About this study

The purpose of this study is to better understand the role of HIV and/or HCV infection on the immune system and potential ways to eliminate the virus(es).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Subjects:

 Inclusion Criteria:

  •  HIV positive donors and/or Hepatitis C Virus (HCV) positive adult (≥18 years of age) donors will be recruited for apheresis by the primary investigator, HIV clinic nurses, or clinic phlebotomists.

Exclusion criteria:

  • Inability to provide informed consent,
  • Pregnancy,
  • Inability to obtain peripheral venous access for the apharesis procedure. 

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Andrew Badley, M.D.

Open for enrollment

Contact information:

James Allen

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20312145

Mayo Clinic Footer